Filing Details
- Accession Number:
- 0001214659-22-000419
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-01-06 16:51:29
- Reporting Period:
- 2022-01-04
- Accepted Time:
- 2022-01-06 16:51:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1579824 | M Charles Baum | C/O Mirati Therapeutics Inc. 3545 Cray Court San Diego CA 92121 | President,Founder,Head Of R&D | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-01-04 | 4,045 | $147.73 | 101,239 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-01-04 | 69 | $149.09 | 101,170 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the restricted stock units (RSUs) granted on January 3, 2020.